Cited 0 times in
Clopidogrel treatment and the MEND-CABG II trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강석민 | - |
dc.contributor.author | 오재원 | - |
dc.date.accessioned | 2015-05-19T16:26:09Z | - |
dc.date.available | 2015-05-19T16:26:09Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 0098-7484 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/106300 | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Coronary Artery Bypass/adverse effects* | - |
dc.subject.MESH | Coronary Artery Bypass/mortality | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Myocardial Infarction/etiology* | - |
dc.subject.MESH | Myocardial Infarction/prevention & control* | - |
dc.subject.MESH | Myocardial Reperfusion Injury/etiology | - |
dc.subject.MESH | Myocardial Reperfusion Injury/prevention & control | - |
dc.subject.MESH | Platelet Aggregation Inhibitors/therapeutic use* | - |
dc.subject.MESH | Purinergic Antagonists* | - |
dc.subject.MESH | Pyridoxal Phosphate/therapeutic use* | - |
dc.subject.MESH | Risk | - |
dc.subject.MESH | Ticlopidine/analogs & derivatives* | - |
dc.subject.MESH | Ticlopidine/therapeutic use | - |
dc.title | Clopidogrel treatment and the MEND-CABG II trial | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Jaewon Oh | - |
dc.contributor.googleauthor | Namki Hong | - |
dc.contributor.googleauthor | Seok-Min Kang | - |
dc.identifier.doi | 10.1001/jama.300.9.1021-a | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00037 | - |
dc.contributor.localId | A02395 | - |
dc.relation.journalcode | J01196 | - |
dc.identifier.eissn | 1538-3598 | - |
dc.identifier.pmid | 18768409 | - |
dc.identifier.url | http://jama.jamanetwork.com/article.aspx?articleid=182490 | - |
dc.subject.keyword | Coronary Artery Bypass/adverse effects* | - |
dc.subject.keyword | Coronary Artery Bypass/mortality | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Myocardial Infarction/etiology* | - |
dc.subject.keyword | Myocardial Infarction/prevention & control* | - |
dc.subject.keyword | Myocardial Reperfusion Injury/etiology | - |
dc.subject.keyword | Myocardial Reperfusion Injury/prevention & control | - |
dc.subject.keyword | Platelet Aggregation Inhibitors/therapeutic use* | - |
dc.subject.keyword | Purinergic Antagonists* | - |
dc.subject.keyword | Pyridoxal Phosphate/therapeutic use* | - |
dc.subject.keyword | Risk | - |
dc.subject.keyword | Ticlopidine/analogs & derivatives* | - |
dc.subject.keyword | Ticlopidine/therapeutic use | - |
dc.contributor.alternativeName | Kang, Seok Min | - |
dc.contributor.alternativeName | Oh, Jae Won | - |
dc.contributor.affiliatedAuthor | Kang, Seok Min | - |
dc.contributor.affiliatedAuthor | Oh, Jae Won | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 300 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 1021 | - |
dc.citation.endPage | 1022 | - |
dc.identifier.bibliographicCitation | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol.300(9) : 1021-1022, 2008 | - |
dc.identifier.rimsid | 56338 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.